News
Vertex seeks to mobilise Sh5 billion for the Bond Fund through the issuance of 50 million units, and a further Sh5 billion ...
By keeping issuance disciplined, the BoT ensures that lower policy rates do not trigger excessive liquidity growth that could ...
Vertex SME Holdings Limited, a private equity vehicle managed by JMMB Securities Limited, is gearing up to raise another $1 billion to fund its pipeline of investment opportunities. Private equity ...
LONDON, July 14, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that it has reached a broad reimbursement agreement with NHS England for Vertex’s cystic fibrosis (CF ...
All eligible people with CF in England can now benefit from this medicine - LONDON - July 15, 2025 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that it has reached a ...
ALYFTREK brings a potentially transformative therapy to up to 60 people living with CF in Canada who were not previously eligible for a CFTR modulator. As the first once-daily CFTR modulator ...
NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most ...
Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis Français ...
Vertex Pharmaceuticals’ triple combination cystic fibrosis (CF) therapy has been recommended by the National Institute for Health and Care Excellence (NICE) to treat patients aged six years and older.
Vertex Pharmaceuticals Incorporated stands second on our list and has recently launched the first non opioid acute pain treatment.
TANZANIA is making notable progress in fostering a knowledge-based economy through the development and strengthening of its Technology and Innovation Support Centres (TISC) network.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results